417 related articles for article (PubMed ID: 15558559)
1. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.
Tanaka YO; Nishida M; Tsunoda H; Okamoto Y; Yoshikawa H
J Magn Reson Imaging; 2004 Dec; 20(6):998-1007. PubMed ID: 15558559
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
[TBL] [Abstract][Full Text] [Related]
5. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
Fadare O; Liang SX
Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcoma of the uterus: MR findings.
Tanaka YO; Tsunoda H; Minami R; Yoshikawa H; Minami M
J Magn Reson Imaging; 2008 Aug; 28(2):434-9. PubMed ID: 18666176
[TBL] [Abstract][Full Text] [Related]
7. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
[TBL] [Abstract][Full Text] [Related]
9. Pathologic considerations of uterine smooth muscle tumors.
Prayson RA; Hart WR
Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
[TBL] [Abstract][Full Text] [Related]
10. P16, Ki67, P53, and WT1 Expression in Uterine Smooth Muscle Tumors: An Adjunct in Confirming the Diagnosis of Malignancy in Ambiguous Cases.
Delgado B; Dreiher J; Braiman D; Meirovitz M; Shaco-Levy R
Int J Gynecol Pathol; 2021 May; 40(3):257-262. PubMed ID: 32897968
[TBL] [Abstract][Full Text] [Related]
11. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of typical polypoid adenomyoma of the uterus in 8 patients: correlation with pathological findings.
Kitajima K; Imanaka K; Kuwata Y; Hashimoto K; Sugimura K
J Comput Assist Tomogr; 2007; 31(3):463-8. PubMed ID: 17538297
[TBL] [Abstract][Full Text] [Related]
13. Foci of decreased signal on T2-weighted MR images in leiomyosarcomas of soft tissue: correlation between MR and histological findings.
Pilavaki M; Drevelegas A; Nenopoulou H; Scordalaki A; Chourmouzi D; Sofroniadis I; Dimitriadis AS
Eur J Radiol; 2004 Sep; 51(3):279-85. PubMed ID: 15294338
[TBL] [Abstract][Full Text] [Related]
14. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
[TBL] [Abstract][Full Text] [Related]
15. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics.
Swe TT; Onitsuka H; Kawamoto K; Ueyama T; Tsuruchi N; Masuda K
Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735
[TBL] [Abstract][Full Text] [Related]
16. Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature.
Vilos GA; Marks J; Ettler HC; Vilos AG; Prefontaine M; Abu-Rafea B
J Minim Invasive Gynecol; 2012; 19(3):288-95. PubMed ID: 22546421
[TBL] [Abstract][Full Text] [Related]
17. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of p53 in cutaneous and subcutaneous leiomyosarcomas.
Fernandez-Flores A; Monteagudo C
Ann Diagn Pathol; 2016 Oct; 24():25-9. PubMed ID: 27649950
[TBL] [Abstract][Full Text] [Related]
20. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
